FBIO (Fortress Biotech) Inventory Turnover: 0.66 (As of Mar. 2026)

What is Fortress Biotech Inventory Turnover?

Fortress Biotech FBIO -1.62% 44 Inventory Turnover is 0.66 as of Mar. 2026. GuruFocus rates FBIO with a GF Score™ of 44/100 and a GF Value™ of $1.24 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Fortress Biotech's Cost of Goods Sold for the three months ended in Mar. 2026 was $6.22 Mil. Fortress Biotech's Average Total Inventories for the quarter that ended in Mar. 2026 was $9.46 Mil. Fortress Biotech's Inventory Turnover for the quarter that ended in Mar. 2026 was 0.66.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Fortress Biotech's Days Inventory for the three months ended in Mar. 2026 was 138.80.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Fortress Biotech's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.59.

Fortress Biotech (NAS:FBIO) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Fortress Biotech's Days Inventory for the three months ended in Mar. 2026 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Mar. 2026 )	/	Cost of Goods Sold (Q: Mar. 2026 )	*	Days in Period
	=	9.458	/	6.218	*	365 / 4
	=	138.80

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Fortress Biotech's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	9.458	/	16.038
	=	0.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

Fortress Biotech Inventory Turnover Related Terms

Fortress Biotech Inventory Turnover Historical Data

* Premium members only.

The historical data trend for Fortress Biotech's Inventory Turnover can be seen below:

Fortress Biotech Inventory Turnover Chart

Fortress Biotech Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Inventory Turnover

Get a 7-Day Free Trial

5.70

2.56

1.88

1.69

1.74

Fortress Biotech Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Inventory Turnover	Get a 7-Day Free Trial															0.36	0.39	0.47	0.51	0.66

44GF Score

Fortress Biotech Inc FBIO

Inventory Turnover is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Fortress Biotech Inventory Turnover Calculation

Fortress Biotech's Inventory Turnover for the fiscal year that ended in Dec. 2025 is calculated as

	Inventory Turnover (A: Dec. 2025 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (A: Dec. 2025 )	/ (	(Total Inventories (A: Dec. 2024 )	+	Total Inventories (A: Dec. 2025 ))	/	count )
=	20.924	/ (	(14.431	+	9.624)	/	2 )
=	20.924	/	12.0275
=	1.74

Fortress Biotech's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

	Inventory Turnover (Q: Mar. 2026 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (Q: Mar. 2026 )	/ (	(Total Inventories (Q: Dec. 2025 )	+	Total Inventories (Q: Mar. 2026 ))	/	count )
=	6.218	/ (	(9.624	+	9.292)	/	2 )
=	6.218	/	9.458
=	0.66

Frequently Asked Questions Learn more about Inventory Turnover →

What does a Inventory Turnover of 0.66 mean?

Fortress Biotech (FBIO) has a Inventory Turnover of 0.66 as of Mar. 2026. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Fortress Biotech and its competitors.

Is Fortress Biotech's Inventory Turnover too high?

Fortress Biotech's current Inventory Turnover is 0.66. Overall, Fortress Biotech has a GF Score™ of 44/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Fortress Biotech's Inventory Turnover compare to RLYB and INO?

Fortress Biotech's Inventory Turnover of 0.66 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Inventory Turnover for a Biotechnology company?

A good Inventory Turnover depends on the Biotechnology industry context. However, Inventory Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Inventory Turnover mean?

A high Inventory Turnover can signal that a stock is expensive relative to its fundamentals. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Fortress Biotech and its competitors. Fortress Biotech's current Inventory Turnover is 0.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Fortress Biotech stock overvalued right now?

Based on GuruFocus' analysis, Fortress Biotech (FBIO) is currently considered Significantly Overvalued. The stock's GF Value™ is $1.24, compared to a current price of $3.03 — trading 144.4% above its estimated fair value. The current Inventory Turnover is 0.66. Fortress Biotech's overall GF Score™ is 44/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Inventory Turnover calculated?

Inventory Turnover is calculated from a company's financial statements. For Fortress Biotech (FBIO), the current Inventory Turnover is 0.66 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fortress Biotech (FBIO) Overvalued in 2026?

Based on GuruFocus' analysis, Fortress Biotech stock appears to be overvalued. The current stock price of $3.03 is trading 144.4% above its estimated GF Value™ of $1.24. GuruFocus considers Fortress Biotech to be Significantly Overvalued.

Key valuation signals for FBIO:

Inventory Turnover: 0.66
GF Value™: $1.24 vs. price of $3.03 (144.4% above fair value)
GF Score™: 44/100 with 6 warning signs

No single metric tells the full story. See the FBIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fortress Biotech Business Description

Industry Healthcare Biotechnology

Comparable Companies RLYB INO SEER NRXS CSBR PYPD ICCC ATRA LONA ANIX VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Other Exchanges FBIOP.PFD:USA CNB0.PFD:Germany

Address 1111 Kane Concourse, Suite 301, Bay Harbor Island, FL, USA, 33154

Website https://www.fortressbiotech.com

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.

44GF Score

Get the complete analysis for FBIO

Inventory Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.03

Price

$1.24

GF Value

View FBIO Analysis

See Inventory Turnover data for all stocks →